Shareholders of Becton, Dickinson and Company (BDX) approved all four proposals at the annual meeting, including the election of directors and an amendment to the equity compensation plan. BD reported record fiscal 2025 results with $21.8 billion in revenue, 25% adjusted operating margin, and 9.6% adjusted EPS growth. The company expects to close the combination of its Biosciences and Diagnostic Solutions business with Waters Corp. on February 9, allocating at least half of the expected $4 billion in cash proceeds to share repurchases. BD highlighted its five-year growth under the BD 2025 strategy and emphasized operational achievements and capital allocation plans.

Read more at Yahoo Finance: Becton, Dickinson Shareholders Approve All Proposals at Annual Meeting, Recap Record FY2025